Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › ND › Grand Forks › NPI 1043309552
Physician

Altru Health System

Altru Health System was paid $29.75M by Medicaid between Jan 2018 and Dec 2024, across 238 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.

33Billing provider infoALTRU HEALTH SYSTEM
GRAND FORKS, ND 58201
33aNPI1043309552assigned 10/12/2006
28Total paid$29.75M
24GClaims568,080
24DCodes billed238
24AFirst – last monthJan 2018 – Dec 2024

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official GOEBEL, DEREK controls 11+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201887,415$3.04M
201982,336$4.05M
202068,650$3.46M
202190,338$4.79M
202287,592$5.02M
202383,932$4.92M
2024incomplete67,817$4.48M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 24% 122,257 107,035 $7.16M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 20% 70,971 62,621 $5.99M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 12% 21,727 19,858 $3.44M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 6.2% 16,488 15,231 $1.83M
99232 Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity 3.7% 23,004 7,499 $1.09M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 2.9% 13,945 13,005 $856K
99233 Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m 2.4% 9,740 3,462 $702K
99223 Prolong inpt eval add15 m 1.9% 3,770 3,121 $576K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1.8% 6,759 6,052 $526K
99239 Hospital discharge day management, more than 30 minutes 1.5% 4,800 4,374 $437K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1.4% 4,019 3,681 $408K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 1.4% 26,306 24,761 $405K
226 more codes
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 1.3% 4,915 $395K
88305 Level IV - Surgical pathology, gross and microscopic examination 1.2% 7,107 $366K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) 1.2% 5,251 $364K
99215 Doctor's office visit, returning patient (complex) 1.2% 3,588 $352K
99203 Doctor's office visit, new patient (routine) <1% 3,927 $252K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 1,423 $246K
90472 Immunization administration, each additional vaccine (list separately) <1% 15,378 $239K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 7,335 $239K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 4,489 $230K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 1,628 $213K
99222 Initial hospital care, per day, moderate complexity <1% 1,933 $201K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 29,268 $188K
90834 Psychotherapy session, about 45 minutes <1% 2,483 $183K
71045 Radiologic examination, chest; single view <1% 20,257 $151K
98941 Chiropractic manipulative treatment; spinal, 3-4 regions <1% 3,549 $150K
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 5,902 $148K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 1,691 $115K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 1,189 $110K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 1,378 $110K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 1,345 $97K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 807 $87K
00170 Anesthesia for intraoral procedures, including biopsy <1% 718 $77K
71046 Radiologic examination, chest; 2 views <1% 8,097 $73K
70450 Computed tomography, head or brain; without contrast material <1% 2,044 $60K
90792 Psychiatric diagnostic evaluation with medical services <1% 301 $59K
99238 Hospital discharge day management, 30 minutes or less <1% 897 $54K
36415 Collection of venous blood by venipuncture <1% 18,013 $50K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,018 $47K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 1,428 $43K
99309 Subsequent nursing facility care, per day, low to moderate complexity <1% 1,903 $43K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,371 $42K
92567 <1% 3,730 $40K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 433 $40K
99221 <1% 691 $40K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 357 $38K
90686 <1% 10,234 $36K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,351 $35K
80053 Comprehensive metabolic panel <1% 3,073 $34K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 125 $34K
77067 Screening mammography, bilateral, including computer-aided detection <1% 863 $31K
20611 <1% 329 $31K
Q3014 Telehealth originating site facility fee <1% 2,035 $30K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 346 $30K
11721 <1% 2,239 $27K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 865 $27K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 810 $27K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 353 $27K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 360 $25K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,100 $25K
92015 Determination of refractive state <1% 2,142 $25K
99205 Prolong outpt/office vis <1% 192 $24K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 262 $24K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 188 $23K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 172 $22K
84443 Thyroid stimulating hormone (TSH) <1% 1,658 $22K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 3,158 $21K
99460 <1% 262 $21K
77063 Screening digital breast tomosynthesis, bilateral <1% 667 $19K
73630 <1% 2,562 $18K
93793 <1% 2,558 $18K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 853 $18K
93298 <1% 612 $16K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 365 $15K
95886 <1% 190 $15K
93294 <1% 763 $15K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 607 $15K
80061 Lipid panel <1% 1,341 $14K
99469 Subsequent inpatient neonatal critical care, per day, 28 days or younger <1% 45 $14K
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results <1% 388 $14K
99308 Subsequent nursing facility care, per day, straightforward <1% 616 $13K
88342 <1% 354 $13K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 580 $12K
83036 Hemoglobin; glycosylated (A1C) <1% 1,562 $12K
76830 Ultrasound, transvaginal <1% 434 $11K
71250 <1% 327 $11K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient <1% 226 $11K
93248 <1% 454 $10K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 42 $10K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 166 $10K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 510 $9K
85027 <1% 1,661 $9K
87631 <1% 80 $9K
90474 <1% 777 $9K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 43 $8K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,308 $8K
95811 <1% 42 $8K
0002A <1% 200 $8K
93297 <1% 438 $7K
90785 <1% 478 $7K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 75 $7K
99217 <1% 154 $7K
73610 <1% 873 $7K
80048 Basic metabolic panel (calcium, ionized) <1% 977 $7K
0001A <1% 229 $6K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 178 $6K
90670 <1% 2,796 $5K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 70 $5K
86780 <1% 554 $5K
92557 <1% 158 $5K
62323 <1% 41 $4K
99480 Subsequent intensive care, per day, low birth weight infant <1% 43 $4K
73562 <1% 593 $4K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 28 $4K
95909 <1% 38 $4K
90715 <1% 290 $4K
99152 <1% 553 $3K
95908 <1% 38 $3K
76937 <1% 452 $3K
82728 <1% 306 $3K
99310 Prolong nursin fac eval 15m <1% 90 $3K
92134 <1% 168 $3K
72141 <1% 41 $3K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 406 $3K
76819 Fetal biophysical profile; without non-stress testing <1% 89 $3K
74018 <1% 394 $3K
95910 <1% 15 $3K
82607 <1% 217 $3K
96127 <1% 956 $3K
95911 <1% 13 $2K
V5266 Battery for use in hearing device <1% 207 $2K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 19 $2K
73030 <1% 245 $2K
90651 <1% 94 $2K
87653 <1% 64 $2K
81003 <1% 993 $2K
90656 <1% 625 $2K
81001 <1% 832 $2K
93922 <1% 248 $2K
87340 <1% 262 $2K
73110 <1% 234 $2K
64615 <1% 39 $2K
90960 End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits <1% 24 $2K
67028 Intravitreal injection of a pharmacologic agent <1% 28 $2K
86140 <1% 404 $2K
93295 <1% 76 $2K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 15 $2K
0004A <1% 30 $2K
98942 <1% 20 $2K
95885 <1% 26 $1K
92002 <1% 25 $1K
01967 Neuraxial labor analgesia/anesthesia for planned vaginal delivery <1% 13 $1K
86803 <1% 121 $1K
93246 <1% 91 $1K
43235 <1% 12 $1K
0071A <1% 73 $1K
88141 <1% 120 $1K
73502 <1% 143 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 105 $1K
72125 Computed tomography, cervical spine; without contrast material <1% 29 $1K
93976 <1% 49 $1K
76801 <1% 29 $1K
93296 <1% 42 $1K
86850 <1% 170 $1K
86769 <1% 40 $920.36
92558 <1% 122 $919.84
97803 <1% 16 $818.22
0072A <1% 48 $759.92
85652 <1% 312 $744.93
82043 <1% 159 $743.53
72100 <1% 69 $738.08
94060 <1% 100 $733.20
70551 Magnetic resonance imaging, brain; without contrast material <1% 12 $659.28
73130 <1% 76 $605.10
94726 <1% 69 $596.19
95800 <1% 12 $566.17
93971 <1% 35 $554.49
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 142 $540.28
71275 Computed tomographic angiography, chest, with contrast material <1% 16 $534.25
76642 <1% 17 $488.91
77001 <1% 35 $478.77
94729 <1% 69 $444.25
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 15 $414.40
92504 <1% 14 $413.47
20610 <1% 25 $370.95
11056 <1% 20 $369.78
87280 <1% 51 $368.82
87210 <1% 90 $332.68
76775 <1% 29 $327.87
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 12 $313.95
86901 <1% 160 $286.97
86900 <1% 160 $286.97
82570 <1% 41 $264.04
80069 <1% 26 $245.43
99421 <1% 15 $220.55
81025 <1% 63 $208.00
74230 <1% 13 $195.73
84156 <1% 41 $187.19
85610 <1% 39 $185.12
99220 <1% 16 $182.64
92587 <1% 27 $174.32
80076 <1% 72 $124.20
90734 <1% 50 $122.31
84439 <1% 12 $115.08
85018 <1% 104 $104.10
82565 <1% 17 $96.73
17110 <1% 15 $78.82
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 63 $72.28
87480 <1% 26 $50.52
87510 <1% 26 $50.52
87660 <1% 26 $50.52
90677 <1% 208 $32.78
90685 <1% 182 $22.26
90658 <1% 12 $21.86
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 14 $8.07
91300 <1% 729 $0.53
91307 <1% 242 $0.33
91305 <1% 32 $0.31
90619 <1% 12 $0.10
90698 <1% 1,807 $0.01
90680 0% 681 $0.00
90744 0% 336 $0.00
90697 0% 226 $0.00
90723 0% 310 $0.00
86762 0% 14 $0.00
90716 0% 35 $0.00
90647 0% 292 $0.00
3074F 0% 93 $0.00
90696 0% 57 $0.00
98943 0% 38 $0.00
90633 0% 543 $0.00
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 0% 12 $0.00
3078F 0% 66 $0.00
90681 0% 65 $0.00
90710 0% 74 $0.00
90707 0% 33 $0.00
83540 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGOEBEL, DEREK (CHIEF FINANCIAL OFFICER)
Same official

Other billing entities under GOEBEL, DEREK

Full network →
ProviderLocationPaid
Altru Health SystemCrookston, MN$1.56M
Altru Health SystemDevils Lake, ND$1.54M
Altru Health SystemRoseau, MN$1.16M
Altru Health SystemWarroad, MN$490K
Altru Health SystemEast Grand Forks, MN$458K
Altru Health SystemThief River Falls, MN$236K
Altru Health SystemGrand Forks, ND$170K
Altru Health SystemGrand Forks, ND$22K
Altru Health SystemGreenbush, MN$9K
Altru Health SystemGrand Forks, ND$2K
Altru Health SystemDrayton, ND$0.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.